Literature DB >> 10587021

Locally advanced breast cancer treated with primary chemotherapy: comparison between magnetic resonance imaging and pathologic evaluation of residual disease.

G Trecate1, E Ceglia, F Stabile, J D Tesoro-Tess, G Mariani, M Zambetti, R Musumeci.   

Abstract

AIMS AND
BACKGROUND: We evaluated the response of locally advanced breast cancer to induction chemotherapy using MRI techniques. The size and vitality of any residual pathologic tissue was quantified by means of morphologic and dynamic analysis. A curve derived from the dynamic parameters shows the uptake intensity with respect to the time elapsed since administration, which is related to vascularization and therefore indirectly reflects the angiogenesis of malignant tissue. METHODS AND STUDY
DESIGN: A group of 30 patients were examined with MRI for staging purposes before undergoing treatment and subsequently to assess the response to treatment. Alterations in size and dynamic parameters were closely monitored.
RESULTS: The overall accuracy was 90%, the sensitivity 96%, the specificity 75%, the positive predictive value 92.5% and the negative predictive value 66%. Interestingly, analysis of the dynamic curves made it possible to obtain additional information regarding the angiogenetic activity of the residual tumor.
CONCLUSIONS: Evaluation of the response to treatment by means of conventional imaging and clinical examination can be particularly difficult because of the fibrosis induced by cytotoxic drugs or the small volume of residual disease. The additional information supplied by MRI could therefore allow a more conservative surgical approach in selected cases of optimal response to treatment, as well as a much more accurate follow-up. Furthermore, the variation in dynamic parameters according to the vitality of residual disease could in the future become a useful tool for monitoring the effectiveness of anti-angiogenetic drugs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10587021     DOI: 10.1177/030089169908500402

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  4 in total

1.  The use of molecular breast imaging to assess response in women undergoing neoadjuvant therapy for breast cancer: a pilot study.

Authors:  Dietlind L Wahner-Roedler; Judy C Boughey; Carrie B Hruska; Beiyun Chen; Deborah J Rhodes; Cindy L Tortorelli; Robert W Maxwell; Stephen S Cha; Michael K O'Connor
Journal:  Clin Nucl Med       Date:  2012-04       Impact factor: 7.794

2.  The use of contrast-enhanced computed tomography before neoadjuvant chemotherapy to identify patients likely to be treated safely with breast-conserving surgery.

Authors:  Sadako Akashi-Tanaka; Takashi Fukutomi; Natsuko Sato; Eriko Iwamoto; Toru Watanabe; Noriyuki Katsumata; Masashi Ando; Kunihisa Miyakawa; Tadashi Hasegawa
Journal:  Ann Surg       Date:  2004-02       Impact factor: 12.969

Review 3.  How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer.

Authors:  Elissa R Price; Jasmine Wong; Rita Mukhtar; Nola Hylton; Laura J Esserman
Journal:  World J Clin Cases       Date:  2015-07-16       Impact factor: 1.337

4.  The diagnostic performance of CESM and CE-MRI in evaluating the pathological response to neoadjuvant therapy in breast cancer: a systematic review and meta-analysis.

Authors:  Sudan Tang; Chunhong Xiang; Quan Yang
Journal:  Br J Radiol       Date:  2020-07-02       Impact factor: 3.039

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.